Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
What the buyer wrote
Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023. Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution). Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Where
- in London
Who the buyer named
Sally Hopkin was the named contact on this notice.
